VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

4D Molecular Therapeutics, Inc. (FDMT) Total Return Calculator with Dividends Reinvested

4D Molecular Therapeutics, Inc.

Popular:

The total return for 4D Molecular Therapeutics, Inc. (FDMT) stock is +238.31% over the past 12 months. So far it's up 42.35% this year. The 5-year total return is -68.97%, meaning $10,000 invested in FDMT stock 5 years ago would be worth $3,103 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in FDMT 1 year ago, it would be worth $33,397 today — you'd have gained $23,397.

With Dividends Reinvested$33,397+233.97%

Price Only (No DRIP)$33,397+233.97%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in FDMT

1Y$33,831+$23,831 (+238.3%)238.3% CAGR

3Y$6,307-$3,693 (-36.9%)-14.2% CAGR

5Y$3,103-$6,897 (-69.0%)-20.9% CAGR

10Y$2,573-$7,427 (-74.3%)-12.7% CAGR

15Y$2,573-$7,427 (-74.3%)-8.7% CAGR

20Y$2,573-$7,427 (-74.3%)-6.6% CAGR

30Y$2,573-$7,427 (-74.3%)-4.4% CAGR

4D Molecular Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading FDMT total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+42.35%	—	+42.35%	—	$14,235
1Y	+238.31%	238.31%	+238.31%	—	$33,831
3Y	-36.93%	-14.24%	-36.92%	—	$6,307
5Y	-68.97%	-20.87%	-68.97%	—	$3,103
10Y	-74.27%	-12.69%	-74.27%	—	$2,573
15Y	-74.27%	-8.65%	-74.27%	—	$2,573
20Y	-74.27%	-6.56%	-74.27%	—	$2,573
30Y	-74.27%	-4.42%	-74.27%	—	$2,573

Risk & Highlights

Best Year+28.64%2025

Worst Year-73.79%2024

Max Drawdown-41.40%2025-10-27 → 2026-01-06

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+31.97%	+31.97%	—	+0.41%	+31.6pp
2025	+28.64%	+28.64%	—	+16.64%	+12.0pp
2024	-73.79%	-73.79%	—	+24.00%	-97.8pp
2023	-1.84%	-1.84%	—	+24.81%	-26.7pp
2022	-1.90%	-1.90%	—	-19.95%	+18.0pp

FDMT outperformed the S&P 500 by 206.99pp over the past year (+238.31% vs +31.32%).

Loading summary...

FDMT Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
FDMT4D Molecular Therapeutics, Inc.	$600M	+4.8%	+42.3%	+238.3%	—	-36.9%	-69.0%	-74.3%
OCGNOcugen, Inc.	$493M	-17.8%	+5.4%	+103.4%	—	+102.6%	-84.8%	-98.5%
KRYSKrystal Biotech, Inc.	$8.5B	+10.3%	+17.0%	+107.1%	—	+229.6%	+310.3%	+2615.2%
RCKTRocket Pharmaceuticals, Inc.	$418M	+11.6%	+11.6%	-38.8%	—	-81.9%	-91.1%	-90.7%
QUREuniQure N.V.	$1.4B	+31.2%	-2.4%	+98.8%	—	+5.6%	-30.6%	+89.1%
EDITEditas Medicine, Inc.	$311M	+16.7%	+54.9%	+138.7%	—	-67.0%	-90.8%	-89.5%
NTLAIntellia Therapeutics, Inc.	$1.6B	+4.1%	+50.4%	+91.0%	—	-67.9%	-79.2%	-37.3%
BEAMBeam Therapeutics Inc.	$3.3B	+33.4%	+19.1%	+102.2%	—	-3.0%	-53.9%	+72.4%
CRSPCRISPR Therapeutics AG	$5.3B	+12.1%	+2.4%	+66.1%	—	-1.6%	-48.9%	+290.9%
PRMEPrime Medicine, Inc.	$616M	+2.1%	-3.4%	+156.4%	—	-75.9%	-77.8%	-53.6%
ARWRArrowhead Pharmaceuticals, Inc.	$11.1B	+29.5%	+16.7%	+505.0%	—	+95.6%	+20.5%	+1315.7%

Compare:FDMT vs OCGN FDMT vs KRYS FDMT vs RCKT FDMT vs OCGN vs KRYS

About FDMT Dividend Returns

4D Molecular Therapeutics, Inc. (FDMT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of FDMT over the past year?

4D Molecular Therapeutics, Inc. (FDMT) delivered a return of 238.31% over the past year. Since FDMT does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in FDMT be worth today?

A $10,000 investment in 4D Molecular Therapeutics, Inc. one year ago would be worth $33,831 today, representing a gain of $23,831.

Q3Does FDMT pay dividends?

4D Molecular Therapeutics, Inc. (FDMT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For FDMT, the total return equals the price-only return.

Q4Did FDMT beat the S&P 500?

Yes, 4D Molecular Therapeutics, Inc. (FDMT) outperformed the S&P 500 by 206.99 percentage points over the past year. FDMT delivered a total return of 238.31%, compared to the S&P 500's 31.32%. This 206.99pp alpha means investors in FDMT earned more than a passive S&P 500 index fund.

Q5What is FDMT's worst drawdown?

4D Molecular Therapeutics, Inc. (FDMT) experienced a maximum drawdown of -41.40% over the past year, declining from its peak on 2025-10-27 to its trough on 2026-01-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is FDMT's long-term total return over 10, 20, or 30 years?

Here are 4D Molecular Therapeutics, Inc. (FDMT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -74.3% (-12.7% CAGR) — $10,000 would have grown to $2,573. Over 20 years: -74.3% total return (-6.6% CAGR) — $10,000 → $2,573. Over 30 years: -74.3% total return (-4.4% CAGR) — $10,000 → $2,573. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was FDMT's best and worst year?

4D Molecular Therapeutics, Inc.'s best calendar year was 2025 with a total return of 28.6%. Its worst year was 2024 with a total return of -73.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 102.4 percentage points.